Xvivo Perfusion AB (XVIPF)

Xvivo Perfusion AB (XVIPF) Financial Statements


Xvivo Perfusion AB Financial Overview

Xvivo Perfusion AB's market cap is currently ―. The company's EPS TTM is $0.062; its P/E ratio is 344.75; Xvivo Perfusion AB is scheduled to report earnings on April 24, 2023, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenuekr 96.83Mkr 94.29Mkr 92.65Mkr 85.86Mkr 54.94M
Gross Profitkr 69.37Mkr 67.51Mkr 65.22Mkr 63.12Mkr 37.94M
EBITkr -4.66Mkr 4.14Mkr 4.62Mkr 17.14Mkr -4.03M
EBITDAkr -4.66Mkr 4.14Mkr 4.62Mkr 17.14Mkr -4.03M
Net Income Common Stockholderskr 5.40Mkr 7.53Mkr 4.76Mkr 12.19Mkr -1.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 314.56Mkr 317.88Mkr 339.78Mkr 398.70Mkr 284.52M
Total Assetskr 1.64Bkr 1.58Bkr 1.52Bkr 1.54Bkr 1.14B
Total Debtkr 5.54Mkr 6.42Mkr 5.14Mkr 5.72Mkr 4.67M
Net Debtkr -309.02Mkr -311.46Mkr -334.64Mkr -392.98Mkr -279.85M
Total Liabilitieskr 259.87Mkr 239.00Mkr 224.98Mkr 257.15Mkr 131.84M
Stockholders Equitykr 1.38Bkr 1.35Bkr 1.30Bkr 1.29Bkr 1.01B
Cash Flow-
Free Cash Flowkr 16.97Mkr -1.56Mkr -9.35Mkr -94.64Mkr -8.46M
Operating Cash Flowkr 16.97Mkr -1.56Mkr -9.35Mkr -562.00Kkr -8.46M
Investing Cash Flowkr -33.72Mkr -34.48Mkr -52.37Mkr -125.16Mkr -20.21M
Financing Cash Flowkr -1.62Mkr -556.00Kkr -1.86Mkr 236.90Mkr -1.36M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Xvivo Perfusion AB Debt to Assets

Xvivo Perfusion AB Cash Flow

Xvivo Perfusion AB Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis